secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ceribell, Inc. (CBLL)
CIK:        0001861107
Form:       8-K
Filed at:   2026-01-05T23:59:59+00:00
Accession:  0001193125-26-001800
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ceribell receives FDA Breakthrough Device Designation for LVO stroke detection system
--------------------------------------------------------------------------------

- FDA Breakthrough Device Designation granted for CeriBell's LVO stroke detection and monitoring solution.
- First-in-class point-of-care EEG technology using existing hardware and AI algorithm to interpret signals.
- Nearly 800,000 annual US strokes; LVO strokes cause 62% of post-stroke dependence and 96% of mortalities.
- Designation supports potential expedited development; follows recent 510(k) clearances for Clarity and delirium screening.
- Targets in-hospital stroke patients, where detection and treatment delays lead to 3x higher mortality.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861107/000119312526001800/0001193125-26-001800-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861107/000119312526001800/cbll-20260105.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-001800

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer